THE BEST SIDE OF NEUROPSYCHOLOGICAL TEST BATTERY FOR DEMENTIA

Simply because individuals that carry the APOE e4 gene variant appear to possess a larger risk of great troubles, the FDA recommends staying tested for that gene variant before beginning treatment with lecanemab or donanemab.All subjects done a set of NAB tests as Element of a more comprehensive, one-session neuropsychological test protocol, which